CD | SD | Min | Max | UC | SD | Min | Max | Total | SD | Min | Max | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Psychosocial factors (Na) | ||||||||||||
FAS (189) | ||||||||||||
No fatigue | 41 (36.3%) | 28 (36.8%) | 69 (36.5%) | |||||||||
Fatigue | 60 (53.1%) | 37 (48.7%) | 97 (51.3%) | |||||||||
Extreme fatigue | 12 (10.6%) | 11 (14.5%) | 23 (12.2%) | |||||||||
Mean value fatigue score | 24.72 | 7.27 | 10 | 40 | 24.71 | 7.54 | 12 | 43 | 24.71 | 7.36 | 10 | 43 |
IBDQ < 171 (active disease) (186) | 66 (58.4%) | 43 (56.6%) | 109 (58.6%) | |||||||||
IBDQ score in pointsb | 158 | 35 | 87 | 222 | 157.1 | 36.5 | 69 | 213 | 157.6 | 35.5 | 69 | 222 |
GAS 0–100 in pointsb (178) | 68.3 | 22.6 | 10 | 100 | 66.9 | 23.9 | 10 | 99 | 67.7 | 23.1 | 10 | 100 |
HADS-A (anxiety) b (187) | 6.68 | 4.1 | 0 | 16 | 6.96 | 4.4 | 0 | 18 | 6.79 | 4.2 | 0 | 18 |
Indicating anxiety (> 10) | 20 (17.9%) | 18 (24.0%) | 38 (20.3%) | |||||||||
HADS-D (depression)b (187) | 5.04 | 4.1 | 0 | 17 | 5.41 | 3.78 | 0 | 16 | 5.19 | 3.96 | 0 | 17 |
Indicating depression (> 10) | 15 (13.5%) | 7 (9.2%) | 22 (11.8%) | |||||||||
McGill Pain Questionnaire (179) | ||||||||||||
Total pain none/ low – mild | 35 (32.7%) | 26 (36.1%) | 61 (34.1%) | |||||||||
Total pain disstressing or worse | 50 (46.7%) | 32 (44.5%) | 82 (45.8%) | |||||||||
Sensoric component of painb (181) | 5.59 | 5.4 | 0 | 21 | 4.75 | 5.78 | 0 | 25 | 5.25 | 5.56 | 0 | 25 |
Affective component of painb (181) | 2.63 | 3.08 | 0 | 12 | 2.12 | 2.56 | 0 | 11 | 2.43 | 2.89 | 0 | 12 |
Current pain on VASb (182) | 1.94 | 2.26 | 0 | 8.3 | 1.16 | 1.73 | 0 | 7.2 | 1.6 | 2.06 | 0 | 8.3 |
Laboratory values (Na) | ||||||||||||
Anaemia (169) | 33 (33.0%) | 28 (40.6%) | 61 (36.1%) | |||||||||
CRP > 7 (163) | 28 (28.9%) | 16 (24.2%) | 44 (27.0%) | |||||||||
Fecal calprotectin > 100 mg/kg (60) | 18 (46.2%) | 17 (81.0%) | 35 (58.3%) |